183 related articles for article (PubMed ID: 37029227)
1. Acetylcholine promotes chronic stress-induced lung adenocarcinoma progression via α5-nAChR/FHIT pathway.
Jiao Y; Kang G; Pan P; Fan H; Li Q; Li X; Li J; Wang Y; Jia Y; Zhang L; Sun H; Ma X
Cell Mol Life Sci; 2023 Apr; 80(5):119. PubMed ID: 37029227
[TBL] [Abstract][Full Text] [Related]
2. Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling.
Zhu P; Jin Z; Kang G; Jia Y; Liu D; Zhang Q; Guo F; Jia Y; Jiao Y; Li J; Sun H; Ma X
Cell Commun Signal; 2022 Aug; 20(1):121. PubMed ID: 35971127
[TBL] [Abstract][Full Text] [Related]
3. The role of α5-nicotinic acetylcholine receptor/NLRP3 signaling pathway in lung adenocarcinoma cell proliferation and migration.
Jia Y; Zhang Q; Liu Z; Pan P; Jia Y; Zhu P; Jiao Y; Kang G; Ma X
Toxicology; 2022 Mar; 469():153120. PubMed ID: 35131329
[TBL] [Abstract][Full Text] [Related]
4. PLEK2 mediates metastasis and invasion via α5-nAChR activation in nicotine-induced lung adenocarcinoma.
Li Q; Li J; Wang J; Wang J; Lu T; Jia Y; Sun H; Ma X
Mol Carcinog; 2024 Feb; 63(2):253-265. PubMed ID: 37921560
[TBL] [Abstract][Full Text] [Related]
5. The α5-nAChR/PD-L1 axis facilitates lung adenocarcinoma cell migration and invasion.
Zhu P; Kang G; Jiao Y; Gui C; Fan H; Li X; Jia Y; Zhang L; Ma X
Hum Cell; 2022 Jul; 35(4):1207-1218. PubMed ID: 35593989
[TBL] [Abstract][Full Text] [Related]
6. α5-nAChR/STAT3/CD47 axis contributed to nicotine-related lung adenocarcinoma progression and immune escape.
Kang G; Jiao Y; Pan P; Fan H; Li Q; Li X; Li J; Wang Y; Jia Y; Wang J; Sun H; Ma X
Carcinogenesis; 2023 Dec; 44(10-11):773-784. PubMed ID: 37681453
[TBL] [Abstract][Full Text] [Related]
7. α5-nAChR and survivin: Two potential biological targets in lung adenocarcinoma.
Zhang Y; Sun Y; Jia Y; Zhang Q; Zhu P; Ma X
J Cell Physiol; 2021 Mar; 236(3):1787-1797. PubMed ID: 33196129
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression.
Wang ML; Hsu YF; Liu CH; Kuo YL; Chen YC; Yeh YC; Ho HL; Wu YC; Chou TY; Wu CW
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957649
[TBL] [Abstract][Full Text] [Related]
9. α5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer.
Chen X; Jia Y; Zhang Y; Zhou D; Sun H; Ma X
J Cell Mol Med; 2020 Feb; 24(4):2497-2506. PubMed ID: 31930655
[TBL] [Abstract][Full Text] [Related]
10. α5-nAChR modulates nicotine-induced cell migration and invasion in A549 lung cancer cells.
Sun H; Ma X
Exp Toxicol Pathol; 2015 Sep; 67(9):477-82. PubMed ID: 26205096
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal activation of α5-nAChR and STAT3 in nicotine-induced human lung cancer cell proliferation.
Zhang Y; Jia Y; Li P; Li H; Xiao D; Wang Y; Ma X
J Genet Genomics; 2017 Jul; 44(7):355-362. PubMed ID: 28750889
[TBL] [Abstract][Full Text] [Related]
12. α5-nAChR associated with Ly6E modulates cell migration via TGF-β1/Smad signaling in non-small cell lung cancer.
Zhang Q; Jia Y; Pan P; Zhang X; Jia Y; Zhu P; Chen X; Jiao Y; Kang G; Zhang L; Ma X
Carcinogenesis; 2022 May; 43(4):393-404. PubMed ID: 34994389
[TBL] [Abstract][Full Text] [Related]
13. α5 Nicotinic acetylcholine receptor mediates nicotine-induced HIF-1α and VEGF expression in non-small cell lung cancer.
Ma X; Jia Y; Zu S; Li R; Jia Y; Zhao Y; Xiao D; Dang N; Wang Y
Toxicol Appl Pharmacol; 2014 Jul; 278(2):172-9. PubMed ID: 24793809
[TBL] [Abstract][Full Text] [Related]
14. Alpha5 Nicotinic Acetylcholine Receptor Contributes to Nicotine-Induced Lung Cancer Development and Progression.
Sun HJ; Jia YF; Ma XL
Front Pharmacol; 2017; 8():573. PubMed ID: 28878681
[TBL] [Abstract][Full Text] [Related]
15. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
[TBL] [Abstract][Full Text] [Related]
16. When "No-Smoking" is not enough: Hypoxia and nicotine acetylcholine receptor signaling may drive lung adenocarcinoma progression in never-smokers.
Pandey N; Chongtham J; Pal S; Ali A; Lalwani S; Jain D; Mohan A; Srivastava T
Biochim Biophys Acta Mol Cell Res; 2023 Feb; 1870(2):119302. PubMed ID: 35649481
[TBL] [Abstract][Full Text] [Related]
17. Activated cholinergic signaling provides a target in squamous cell lung carcinoma.
Song P; Sekhon HS; Fu XW; Maier M; Jia Y; Duan J; Proskosil BJ; Gravett C; Lindstrom J; Mark GP; Saha S; Spindel ER
Cancer Res; 2008 Jun; 68(12):4693-700. PubMed ID: 18559515
[TBL] [Abstract][Full Text] [Related]
18. α5-nAChR/ADAM10 signaling mediates nicotine-related cutaneous melanoma progression via STAT3 activation.
Li X; Meng X; Fan H; Wang Y; Jia Y; Jiao J; Ma X
Arch Dermatol Res; 2024 May; 316(6):269. PubMed ID: 38795191
[TBL] [Abstract][Full Text] [Related]
19. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
20. Role of nicotinic acetylcholine receptors in cell proliferation and tumour invasion in broncho-pulmonary carcinomas.
Medjber K; Freidja ML; Grelet S; Lorenzato M; Maouche K; Nawrocki-Raby B; Birembaut P; Polette M; Tournier JM
Lung Cancer; 2015 Mar; 87(3):258-64. PubMed ID: 25601486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
